{"id":"W1596694562","doi":"10.1111/j.1528-1167.2011.03364.x","title":"The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: Implications for clinical use","year":2012,"lang":"en","type":"article","venue":"Epilepsia","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"U.S. Food and Drug Administration; UCB Pharma; Valeant Pharmaceuticals International; GlaxoSmithKline","keywords":"Anticonvulsant; Medicine; Epilepsy; Adverse effect; Pharmacology; Neuroprotection; Neuroscience; Anesthesia; Psychology; Psychiatry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001121458,0.0001114179,0.000263013,0.0001101787,0.0001572297,0.00001877834,0.000599019,0.00005748788,0.00000978359],"category_scores_gemma":[0.002790496,0.00007986459,0.0001305932,0.000545377,0.0008615642,0.0003548363,0.0001641511,0.0002787172,0.000007577702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001319063,"about_ca_system_score_gemma":0.00008579129,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006672162,"about_ca_topic_score_gemma":0.00000172948,"domain_scores_codex":[0.9978918,0.0003843398,0.0006298688,0.0003405315,0.0001996344,0.0005537933],"domain_scores_gemma":[0.9943234,0.004844597,0.0002010887,0.0004563362,0.00004694478,0.0001276311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004292081,0.000644405,0.0890442,0.0000119567,0.000002409551,0.000001699118,0.00006126846,0.00002158331,0.8804277,0.02830949,0.0006554992,0.0003905877],"study_design_scores_gemma":[0.001077199,0.0005322378,0.4213576,0.0000103924,0.0000125169,0.00001164657,0.000009227346,0.002093438,0.5728894,0.0009577445,0.0009524901,0.00009612078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960889,0.00005505705,0.00005739154,0.002685216,0.0003039903,0.0006681918,0.00003571373,0.00001675253,0.0000887974],"genre_scores_gemma":[0.9984843,0.0009494864,0.00004930851,0.0002511968,0.00008493755,0.00004318414,4.745457e-7,0.00001679322,0.0001203548],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3323134,"threshold_uncertainty_score":0.3340685,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3028121105447957,"score_gpt":0.4634071685571768,"score_spread":0.1605950580123811,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}